A population-based cohort of drug exposures and adverse pregnancy outcomes in China (DEEP): rationale, design, and baseline characteristics-Reference-Cited by-同舟云学术

A population-based cohort of drug exposures and adverse pregnancy outcomes in China (DEEP): rationale, design, and baseline characteristics

Published:2024-04 Issue:4 Volume:39 Page:433-445
ISSN:0393-2990
Container-title:European Journal of Epidemiology
language:en
Short-container-title:Eur J Epidemiol

Author:

Tan Jing,Xiong Yiquan,Liu Chunrong,Zhao Peng,Gao Pei,Li Guowei,Guo Jin,Li Mingxi,Wei Wanqiang,Yao Guanhua,Qian Yongyao,Ye Lishan,Qi Huanyang,Liu Hui,Chen Moliang,Zou Kang,Thabane Lehana,Sun Xin^ORCID

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Sichuan Youth Science and Technology Innovation Research Team

China Medical Board

the Fundamental Research Funds for the Central public welfare research institutes

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10654-024-01124-6.pdf

Reference40 articles.

1. Collaborative Group On Drug Use In Pregnancy C. An international survey on drug utilization during pregnancy. Int J risk Saf Med. 1991;2(6):345–9. https://doi.org/10.3233/jrs-1991-2606.

2. Mitchell AA, Gilboa SM, Werler MM, Kelley KE, Louik C, Hernández-Díaz S. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):e511–8. https://doi.org/10.1016/j.ajog.2011.02.029.

3. Emanuel M, Rawlins M, Duff G, Breckenridge A. Thalidomide and its sequelae. Lancet (London England). 2012;380(9844):781–3. https://doi.org/10.1016/s0140-6736(12)60468-1.

4. Bjørk MH, Zoega H, Leinonen MK, et al. Association of Prenatal Exposure to antiseizure medication with risk of Autism and Intellectual Disability. JAMA Neurol. 2022;79(7):672–81. https://doi.org/10.1001/jamaneurol.2022.1269.

5. Diav-Citrin O, Shechtman S, Weinbaum D, et al. Paroxetine and fluoxetine in pregnancy: a prospective, multicentre, controlled, observational study. Br J Clin Pharmacol. 2008;66(5):695–705. https://doi.org/10.1111/j.1365-2125.2008.03261.x.